Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: More Hawk communication re USPTO

Re your sumation:

Good: Maybe nobody is considering it to be that big of a deal so no reason to expressly make it part of settlement discussions.

Bad: I think we were all hoping for it to be a triggering event and that companies were lined up just waiting for that validation.



Great summary and I agree, but both conclusions seem to be bad news in the end result. Either way we get no great increase in sales now, nor as a result of (if/when) there is a favorable USPTO outcome.

Share
New Message
Please login to post a reply